Literature DB >> 12447927

Frontal lobe atrophy due to a mutation in the cholesterol binding protein HE1/NPC2.

Hans H Klünemann1, Milan Elleder, Wolfgang E Kaminski, Karen Snow, Janis M Peyser, John F O'Brien, David Munoz, Gerd Schmitz, Helmfried E Klein, William W Pendlebury.   

Abstract

This is the first description of slowly progressive Niemann-Pick disease type C (NPC) without the typical lysosomal storage in bone marrow and viscera in two descendants of a group of 17th century French-Canadians. The index patient was a married 43-year-old woman with onset of dementia in her thirties, later followed by the development of ataxia and athetoid movements. Her autopsy disclosed frontal lobe atrophy, neurolysosomal storage with oligolamellar inclusion and tau-positive neurofibrillary tangles. Of the 119 family members screened, only a married 42-year-old sister displayed symptoms of a dementia. Both women displayed vertical supranuclear ophthalmoplegia; expressive aphasia; concrete, stimulus-bound, perseverative behavior; and impaired conceptualization and planning. Cultured fibroblasts showed decreased cholesterol esterification and positive filipin staining, but no mutation was detected in coding or promoter regions of the NPC1 gene using conformation sensitive gel electrophoresis and sequencing. Sequencing showed a homozygous gene mutation that is predicted to result in an amino acid substitution, V39M, in the cholesterol binding protein HE1 (NPC2). Adult-onset NPC2 with lysosomal storage virtually restricted to neurons represents a novel phenotypic and genotypic variant with diffuse cognitive impairment and focal frontal involvement described for the first time.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447927     DOI: 10.1002/ana.10366

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

1.  Characterization of a spontaneous novel mutation in the NPC2 gene in a cat affected by Niemann Pick type C disease.

Authors:  Stefania Zampieri; Ezio Bianchi; Carlo Cantile; Roberta Saleri; Bruno Bembi; Andrea Dardis
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

2.  Saccharomyces cerevisiae Npc2p is a functionally conserved homologue of the human Niemann-Pick disease type C 2 protein, hNPC2.

Authors:  Adam C Berger; Thomas H Vanderford; Kim M Gernert; J Wylie Nichols; Victor Faundez; Anita H Corbett
Journal:  Eukaryot Cell       Date:  2005-11

3.  Subcortical volumetric reductions in adult Niemann-Pick disease type C: a cross-sectional study.

Authors:  M Walterfang; B Patenaude; L A Abel; H Kluenemann; E A Bowman; M C Fahey; P Desmond; W Kelso; D Velakoulis
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-13       Impact factor: 3.825

4.  Niemann-Pick Type C-2 Disease: Identification by Analysis of Plasma Cholestane-3β,5α,6β-Triol and Further Insight into the Clinical Phenotype.

Authors:  J Reunert; A S Lotz-Havla; G Polo; F Kannenberg; M Fobker; M Griese; E Mengel; A C Muntau; P Schnabel; O Sommerburg; I Borggraefe; A Dardis; A P Burlina; M A Mall; G Ciana; B Bembi; A B Burlina; T Marquardt
Journal:  JIMD Rep       Date:  2015-03-13

5.  [Niemann-Pick disease type C--a neurometabolic disease through disturbed intracellular lipid transport].

Authors:  A J Grau; M Weisbrod; E Hund; K Harzer
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

Review 6.  Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  Orphanet J Rare Dis       Date:  2010-06-03       Impact factor: 4.123

7.  Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian patients: identification and structural modeling of novel mutations.

Authors:  Tatiana Fancello; Andrea Dardis; Camillo Rosano; Patrizia Tarugi; Barbara Tappino; Stefania Zampieri; Elisa Pinotti; Fabio Corsolini; Simona Fecarotta; Adele D'Amico; Maja Di Rocco; Graziella Uziel; Sebastiano Calandra; Bruno Bembi; Mirella Filocamo
Journal:  Neurogenetics       Date:  2009-02-28       Impact factor: 2.660

8.  Structural basis of sterol binding by NPC2, a lysosomal protein deficient in Niemann-Pick type C2 disease.

Authors:  Sujuan Xu; Brian Benoff; Heng-Ling Liou; Peter Lobel; Ann M Stock
Journal:  J Biol Chem       Date:  2007-06-14       Impact factor: 5.157

9.  Inhibition of Sirtuin 2 with Sulfobenzoic Acid Derivative AK1 is Non-Toxic and Potentially Neuroprotective in a Mouse Model of Frontotemporal Dementia.

Authors:  Tara L Spires-Jones; Leora M Fox; Anete Rozkalne; Rose Pitstick; George A Carlson; Aleksey G Kazantsev
Journal:  Front Pharmacol       Date:  2012-03-12       Impact factor: 5.810

10.  Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease.

Authors:  Natalia Friedland; Heng-Ling Liou; Peter Lobel; Ann M Stock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.